http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2098846-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a8659631bf38b3a590c0d3edc265492c |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D473-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D473-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-522 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-52 |
| filingDate | 1991-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4d87c94fd24a9295559e2d84969c3138 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9a18212a0e5b4cb1d2753f56d8671807 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eeea690dfe06f36673410434079f3c60 |
| publicationDate | 1992-06-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CA-2098846-A1 |
| titleOfInvention | Xanthine derivatives |
| abstract | A compound of formula (I) or, if appropriate, a pharmaceutically acceptable salt thereof, wherein R1 and R2 each independently represent an alkyl group or a moiety of formula (a): -(CH2)m-A, wherein m represents zero or an integer 1, 2 or 3 and A represents a substituted or unsubstituted cyclic hydrocarbon radical; R3 represents hydrogen, NO2 or a halogen atom, an alkoxy group or a group of formula NRsRt wherein Rs and Rt each independently represent hydrogen or alkyl or Rs and Rt together with the nitrogen to which they are attached form a phthalimido group, the phthalimido group being substituted or unsubstituted in the phenylene moiety or R3 represents a moiety of formula (b), wherein R5 represents substituted or unsubstituted alkyl or a substituted or unsubstituted aryl group; and R6 represents hydrogen or a group SO2R7 wherein R7 represents substituted or unsubstituted alkyl, a substituted or unsubstituted aryl group; R4 represents SO2R8, wherein R8 represents substituted or unsubstituted alkyl or a substituted or unsubstituted aryl group, or, when R3 represents a moiety of the above-defined formula (b), then R4 represents hydrogen or a substituted or unsubstituted alkyl group or a benzyl group substituted or unsubstituted in the phenyl ring, a process for preparing such a compound, a composition comprising such a compound and the use of such a compound and composition in medicine. |
| priorityDate | 1990-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 204.